REVIEW COPD AND
α1-ANTITRYPSIN DEFICIENCY
Targeted screening programmes in COPD: how to identify individuals with α1-antitrypsin deficiency Joanna Chorostowska-Wynimko Affiliation: Dept of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland. Correspondence: Joanna Chorostowska-Wynimko, Dept of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland. E-mail:
[email protected]
ABSTRACT α1-antitrypsin deficiency (AATD) is a significantly under-recognised autosomal genetic disorder with
